You are reading premium content from The Dark Report, your primary resource for running an efficient and profitable laboratory.

Get Unlimited Access to The Dark Report absolutely FREE!

You have read 0 of 1 of your complimentary articles this month

Privacy Policy: We will never share your personal information.
October 29, 2012 "Intelligence: Late Breaking Lab News" - The Dark Intelligence Group

October 29, 2012 “Intelligence: Late Breaking Lab News”

Share on facebook
Share on twitter
Share on linkedin
Share on print
Share on email

OURLab and its parent company, Prost Data, Inc., of Nashville, Tennessee, entered into an agreement to be sold to Opko Health Inc., of Miami, Florida. The purchase price of $40 million will be paid as $9.4 million in cash and $30.6 million in stock. Publicly-traded Opko has both pharmaceutical and diagnostic product lines. Jonathan Oppenheimer, M.D., founder of Oppenheimer Urologic Reference Laboratory (OURLab) will become Chief Executive Officer of OPKO’s diagnostics division.

MORE ON: Opko

Opko says that it will use OURLab to help it launch and sell its 4Kscore test, which it describes as a “novel panel of kallikrein biomarkers and associated algorithms for the detection of prostate cancer.” Opko is launching this test in Europe. Opko says that its proprietary test, “has been demonstrated in more than 10,000 patients to predict the probability of positive biopsies in men suspected of having prostate cancer… and use of the 4Kscore may reduce the number of unnecessary prostate biopsies by 50% or more.”

TRANSITIONS

    • Rosetta Genomics of Philadelphia, Pennsylvania, announced that E. Robert Wassman, M.D., will serve in the new position of Chief Medical Officer and Chief Scientific Officer. Wassman, has held executive positions with Generation Health, Genzyme Genetics, Alfigen, Good Start Genetics, Genetrix, and Specialty Laboratories.
    • StrataDx of Lexington, Massachusetts, hired Jim Agnello to be Chief Financial Officer. Agnello has held executive positions with such lab companies as Clarient, Genzyme Genetics/Impath, and SmithKline Beecham Clinical Laboratories. StrataDX also hired Greg Richard as its new Executive Vice President of Sales and Marketing. Richard formerly held executive positions at Laboratory Corporation of America and Quest Diagnostics Incorporated.
    • Pacific Diagnostic Laboratories (PDL) of Santa Barbara, California, has appointed Sonny Varadan as its Chief Information Officer. PDL is a client laboratory of the Nichols Management Group. Varadan was most recently the Vice President and CIO of Pathology Associates Medical Laboratories, and was formerly the Interim CIO for Providence Health Care of Spokane, Washington.

Dark Daily Update

dark_daily_logoHave you caught the latest e-briefings from DARK Daily? If so, then you’d know about…

…the new policy report by the Institute of Medicine that challenges the American healthcare system to adopt the techniques of continuous improvement, including Lean and Six Sigma, ISO 9001, and ISO 15189.

You can get the free DARK Daily e-briefings by signing up at www.darkdaily.com.

Comments

Leave a Reply

Powered by Americaneagle.com

Hosted by Americaneagle.com, Inc.